Glucagon-like peptide-1 (GLP-1) receptor agonists have gained significant attention as versatile treatments for diabetes, obesity, and cardiovascular conditions. These medications mimic a naturally occurring hormone in the body that regulates blood sugar levels, slows digestion, and suppresses appetite. In addition to these approved uses, researchers are exploring their potential benefits in other areas like Alzheimer’s […]
